RecallDepth
Class II Ongoing

RECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only, Takeda Pharmaceuticals USA, Cambridge, MA 02142, NDC: 00944-2843-01

Company
Cardinal Health Inc.
Recall Initiated
July 30, 2025
Posted
August 13, 2025
Recall Number
D-0573-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3 units
Firm Location
Dublin, OH, United States

Reason for Recall

CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

Distribution

Nationwide Within the U.S.

Lot / Code Info

Lot: TRB23802AC, Expires: 03/18/2026; TRA22804AA, Expires: 10/18/2025

More recalls by Cardinal Health Inc.

View all recalls by this company →

Other recent Class II Drug recalls